Motivation to quit using substances among individuals with schizophrenia: Implications for a motivation-based treatment model

Schizophrenia Bulletin

Volumn 23, Issue 2, 1997, Pages 229-238

  Ziedonis, Douglas M ^a,b   Trudeau, Kimberlee ^a,b  

^a Yale University School of Medicine   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; OPIATE;

ADULT; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; SCHIZOIDISM; SCHIZOPHRENIA; SUBSTANCE ABUSE;

EID: 0030922127     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/schbul/23.2.229     Document Type: Article

References (40)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., revised. Washington, DC: The Association, 1987.
2. Ananth, J.; Vanderwater, S.; Kamal, M.; and Brodsky, A. Missed diagnosis of substance abuse in psychiatric patients. Hospital and Community Psychiatry, 40:297-299, 1989.
3. Buckley, P.B.; Thompson, P.; Way, L.; and Meltzer, H.Y. Substance abuse among patients with treatment-resistant schizophrenia: Characteristics and implications for clozapine therapy. American Journal of Psychiatry, 151:385-389, 1994.
4. Davidson, L.; Simsarian, J.; and Marcus, K. Providing Services to Persons Dually Diagnosed With Prolonged Mental Illness and Substance Abuse: A Report. Hartford, CT: Department of Mental Health, 1993.
5. Dixon, L.; Haas, G.; Weiden, P.J.; Sweeney, J.; and Frances, A.J. Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. American Journal of Psychiatry, 148:224-230, 1991.
6. Drake, R.E.; McHugo, G.J.; and Noordsy, D.L. Treatment of alcoholism among schizophrenic outpatients: 4-year outcomes. American Journal of Psychiatry, 150(2):328-329, 1993.
7. Evans, K., and Sullivan, J.M. Dual Diagnosis: Counseling the Mentally Ill Substance Abuser. New York, NY: Guilford Press, 1990.
8. Fischer, D.E.; Halikas, J.A.; Baker, J.W.; and Smith, J.B. Frequency and patterns of drug abuse in psychiatric patients. Diseases of the Nervous System, 36(10):550-553, 1975.
9. Galanter, M.; Castaneda, R.; and Ferman, J. Substance abuse among general psychiatric patients: Place of presentation, diagnosis and treatment. American Journal of Drug and Alcohol Abuse, 14:211-235, 1988.
10. George, T.P.; Sernyak, M.J.; Ziedonis, D.M.; and Woods, S.W. Effects of clozapine on smoking in chronic schizophrenic outpatients. Journal of Clinical Psychiatry, 56(8):344-346, 1995.
11. Glazer, W.M., and Kane, J.M. Depot neuroleptic therapy: An underutilized treatment option. Journal of Clinical Psychiatry, 53:426-433, 1992.
12. Hall, R.C.W.; Popkin, M.D.; DeVaul, R.; and Stickney, S.K. The effect of unrecognized drug abuse on diagnosis and therapeutic outcome. American Journal of Drug and Alcohol Abuse, 4:455-465, 1977.
13. Hazelden Foundation. Dual Disorders Recovery Book. Center City, MN: The Foundation, 1993.
14. Karoly, P. Person variables in therapeutic change and development. In: Karoly, P., and Steffen, J.J., eds. Improving the Long-Term Effects of Psychotherapy. New York, NY: Gardner, 1980. pp. 195-261.
15. Knoedler, W. How training in community living programs helps its patients work. New Directions in Mental Health Services, 2:57-66, 1979.
16. Larsen, E. Stage II Recovery: Life beyond Addiction. New York, NY: Harpercollins, 1985.
17. McEvoy, J.; Freudenreich, O.; Levin, E.D.; and Rose, J.E. Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology, 119(1):124-126, 1995a.
18. McEvoy, J.; Freudenreich, O.; McGee, M.; VanderZwaag, C.; Levin, E.; and Rose, J. Clozapine decreases smoking in patients with chronic schizophrenia. Biological Psychiatry, 37(8):550-552, 1995b.
19. Miller, N.S., Belkin, B.M., and Gibbons, R. Clinical diagnosis of substance use disorders in private psychiatric populations. Journal of Substance Abuse Treatment, 11(4):387-392, 1994.
20. Miller, W.R. Motivation for treatment: A review with special emphasis on alcoholism. Psychological Bulletin, 98(1):84-107, 1985.
21. Miller, W.R., and Rollnick, S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York, NY: Guilford Press, 1991.
22. Miller, W.R.; Zweben, A.; DiClemente, C.C.; and Rychtarik, R.G. Motivational Enhancement Therapy Manual. Rockville, MD: U.S. Department of Health and Human Services, Publication No. (ADM):92-1894, 1992.
23. Mueser, K.T.; Yarnold, P.R.; Levinson, D.F.; Singh, H.; Bellack, A.S.; Kee, K.; Morrison, R.L.; and Yalalam, K.G. Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Schizophrenia Bulletin, 16(1):31-56, 1990.
24. Pepper, B., and Ryglewicz, H. The young adult chronic patient: A new focus. In: Talbott, J., ed. The Chronic Mental Patient: Five Years Later. New York, NY: Grune & Stratton, 1984. pp. 33-48.
25. Prochaska, J.O., and DiClemente, C.C. Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51(3):390-395, 1983.
26. Prochaska, J.O.; DiClemente, C.C.; and Norcross, J.C. In search of how people change: Applications to addictive disorders. American Psychologist, 47:1102-1114, 1992.
27. Prochaska, J.O.; Welicer, W.F.; Rossi, J.S.; Goldstein, M.J.; Marcus, B.H.; Rabowski, W.; Fiore, C.; Harlow, L.L.; Redding, C.A.; Rosenbloom, D.; and Rossi, S.R. Stages of change and decisional balance for 12 problem behaviors. Health Psychology, 13(1):39-46, 1994.
28. Regier, D.A.; Farmer, M.E.; Rae, D.S.; Locke, B.Z.; Keith, S.J.; Judd, L.L.; and Goodwin, F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Journal of the American Medical Association, 264:2511-2518, 1990.
29. Ries, R.K., and Ellingson, T. A pilot assessment at 1 month of 17 dual diagnosis patients. Hospital and Community Psychiatry, 41:1230-1233, 1990.
30. Rossi, J.S.; Rosenbloom, D.; Monti, P.M.; Rohsenow, D.J.; Prochaska, J.O.; and Martin, R.A. "Transtheoretical Model of Behavior Change for Cocaine Use." Presented at the Annual Meeting of the American Psychological Association, Toronto, Ontario, Canada, August 1993.
31. Schneier, F.R., and Siris, S.G. A review of psychoactive substance use and abuse in schizophrenia: Patterns of drug choice. Journal of Nervous and Mental Disease, 175(11):641-652, 1987.
32. Selzer, J.A., and Lieberman, J.A. Schizophrenia and substance abuse. Psychiatric Clinics of North America, 16(2):401-412, 1993.
33. Sevy, S.; Kay, S.R.; Opler, L.A.; and van Pragg, H.M. Significance of cocaine history in schizophrenia. Journal of Nervous and Mental Disease, 178:642-648, 1990.
34. Sisson, R., and Azrin, N. The community reinforcement approach. In: Hester, R.K., and Miller, W.R., eds. Handbook of Alcoholism Treatment Approaches. New York, NY: Pergamon Press, 1989. pp. 242-258.
35. Sterne, M.W., and Pittman, D.J. The concept of motivation: A source of institutional and professional blockage in the treatment of alcoholics. Quarterly Journal of Studies on Alcohol, 26:41-57, 1965.
36. Trudeau, K.J., and Reich, R. Correlates of psychological mindedness. Personality and Individual Differences, 19(5):694-704, 1995.
37. Ziedonis, D.M. Comorbid psychopathology and cocaine addiction. In: Kosten, T.R., and Kleber, H.D., eds. Clinician's Guide to Cocaine Addiction: Theory, Research and Treatment. New York, NY: Guilford Press, 1992. pp. 337-360.
38. Ziedonis, D.M., and Fisher, W. Assessment and treatment of comorbid substance abuse in individuals with schizophrenia. Psychiatric Annals, 24:477-483, 1994.
39. Ziedonis, D.M., and Fisher, W. Motivation-based assessment and treatment of substance abuse in patients with schizophrenia. Directions in Psychiatry, 16(11):1-8, 1996.
40. Ziedonis, D.M.; Kosten, T.R.; Glazer, W.M.; and Frances, R.J. Nicotine dependence and schizophrenia. Hospital and Community Psychiatry, 45:204-206, 1994.